Cargando…
A small molecule high throughput screening platform to profile conformational properties of nascent, ribosome-bound proteins
Genetic mutations cause a wide spectrum of human disease by disrupting protein folding, both during and after synthesis. Transient de-novo folding intermediates therefore represent potential drug targets for pharmacological correction of protein folding disorders. Here we develop a FRET-based high-t...
Autores principales: | Shishido, Hideki, Yoon, Jae Seok, Skach, William R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847357/ https://www.ncbi.nlm.nih.gov/pubmed/35169219 http://dx.doi.org/10.1038/s41598-022-06456-5 |
Ejemplares similares
-
Nuclear translation visualized by ribosome-bound nascent chain puromycylation
por: David, Alexandre, et al.
Publicado: (2012) -
Nascent peptide assists the ribosome in recognizing chemically distinct small molecules
por: Gupta, Pulkit, et al.
Publicado: (2016) -
Folding stabilities of ribosome-bound nascent polypeptides probed by mass spectrometry
por: Tan, Ruiyue, et al.
Publicado: (2023) -
Selective stalling of human translation through small-molecule engagement of the ribosome nascent chain
por: Lintner, Nathanael G., et al.
Publicado: (2017) -
CFTR trafficking mutations disrupt cotranslational protein folding by targeting biosynthetic intermediates
por: Shishido, Hideki, et al.
Publicado: (2020)